针对细胞癌的RNA向疗法的进展
Hanzhong Zhang1, Anqi Lin2, Chen Cai3
1Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
European journal of pharmacology
|May 31, 2025
概括
以RNA为向的疗法通过克服耐药性和增强免疫疗法来治疗细胞癌 (RCC) 是有前途的. 这些先进的策略为改善这种具有挑战性的癌症患者结果提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 细胞癌 (RCC) 由于对传统治疗的耐药性,死亡率很高.
- 针对RNA的疗法提供了一种新的方法来应对RCC的治疗挑战.
研究的目的:
- 审查RNA向疗法在提高RCC治疗疗效方面的潜力.
- 探索它们在克服药物耐药性和改善免疫治疗反应中的作用.
- 讨论个性化医疗和RCC的先进传递机制.
主要方法:
- 对RNA向策略的临床前数据的审查,包括反意义寡核化物 (ASOs),siRNAs,aptamers,mRNAs,miRNAs,shRNAs,CRISPR/Cas9和sgRNAs.
- 在RCC模型中分析它们的疗效.
- 讨论与现有疗法和个性化医学的整合.
主要成果:
- 针对RNA的疗法在临床前RCC模型中显示出高的特异性和有效性.
- 这些模式显示出增强向治疗,克服耐药性和促进免疫治疗的潜力.
- 突出了它们在RCC进展和个性化治疗策略中的作用.
结论:
- 以RNA为向的疗法代表了改善细胞癌治疗的前沿.
- 优化交付和整合这些与当前的治疗是最大限度地提高疗效的关键.
- 个性化医疗方法对于提高RCC患者的治疗结果至关重要.
关键词:
反意义的寡核酸 (ASO) 是一种反意义的寡核酸.亚博体育官网 亚博体育官网 亚博体育官网 亚博体育官网 亚博体育官网微RNA (miRNA) 是一种微型RNA.个性化医疗是个性化的医疗.针对RNA的向疗法细胞癌 (RCC) 是一种细胞癌.小干扰RNAs (siRNA) 是一种小干扰RNA.更多相关视频
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
13.7K
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
10.5K
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:15Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K